RxDoctor Payments Data

Ryle Przybylowicz, MD

Clinical Cardiac Electrophysiology · Portland, ORNPI 1992183479

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (40.4%), food and beverage and grants — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Abbott at 45.4% of the total. Reporting peaked in 2024 at $4,525 and has fallen 66.4% since, to $1,519 in 2025.

$9,975in general payments, 2019–2025

Across 76 payments — averaging $131.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$5K
  • Medtronic$3K
  • Biotronik Inc.$2K
  • Biosense Webster, Inc.$409
  • Philips North America LLC$312
  • Boston Scientific$210
  • plus $297 from 3 others

What the payments were for

  • Grants$2,00020%
  • Travel & lodging$4,03340%
  • Food & beverage$3,33133%
  • Education$6116%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,975 in reported general payments places this provider in the 60th percentile of 37 clinical cardiac electrophysiology providers in Oregon.

See all clinical cardiac electrophysiology providers in Oregon

Medicare billing

Part B allowed, 2024
$25,209
Medicare patients
55
Services billed
129

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Metoprolol Succinate12$98

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Portland

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →